EPTRI is a biotechnology startup based in Belgium with the motto #childrenfirst. Founded in 2017, EPTRI operates as a distributed research infrastructure focusing on basic, preclinical, and translational pediatric research. The company recognizes the significance of growth and ontogeny characteristics in pediatric drug response, emphasizing the integration of preclinical and clinical research. EPTRI's Thematic Research Platforms (TRPs) and high-quality services aim to drive advancements in pediatric medicines and therapeutic and diagnostic approaches. By addressing research gaps and providing comprehensive support throughout various research phases, EPTRI strives to enhance the development and availability of safe and effective treatments for the pediatric population. Currently, there is no available information about their last investment or investors. The company's innovative approach to pediatric research positions it as a promising prospect within the biotechnology industry.
There is no investment information
No recent news or press coverage available for EPTRI.